{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:12:36Z","timestamp":1788484356811,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02384-4","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:44:32Z","timestamp":1782157472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of TNF-\u03b1 in Human Precision-Cut Liver Slices and its Implications for Metabolic Dysfunction-Associated Steatohepatitis Progression"],"prefix":"10.1007","volume":"49","author":[{"given":"Ke","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Gorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorenda","family":"Oosterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2384_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"Mary E Rinella","year":"2023","unstructured":"Rinella, Mary E., A. Brent, Mohammad Shadab Neuschwander-Tetri, F. Siddiqui, Manal, Stephen Abdelmalek, Diana Caldwell, David E. Barb, Kleiner, and Rohit Loomba. 2023. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77:1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"2384_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"Zobair M Younossi","year":"2023","unstructured":"Younossi, Zobair M., Pegah Golabi, James M. Paik, Austin Henry, and Catherine Van Dongen, Linda Henry. 2023. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology 77:1335\u20131347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"key":"2384_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DavidE. Kleiner","year":"2005","unstructured":"Kleiner, David E.., Elizabeth M.. Brunt, Mark Van Natta, Cynthia Behling, Melissa J.. Contos, Oscar W.. Cummings, Linda D.. Ferrell, et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology"},{"key":"2384_CR4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"Herbert Tilg","year":"2010","unstructured":"Tilg, Herbert, and Alexander R. Moschen. 2010. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52:1836\u20131846. https:\/\/doi.org\/10.1002\/hep.24001","journal-title":"Hepatology"},{"key":"2384_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"Susanne Schuster","year":"2018","unstructured":"Schuster, Susanne, Daniel Cabrera, Marco Arrese, and Ariel E. Feldstein. 2018. Triggering and resolution of inflammation in NASH. Nature Reviews Gastroenterology & Hepatology 15:349\u2013364. https:\/\/doi.org\/10.1038\/s41575-018-0009-6","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"2384_CR6","doi-asserted-by":"publisher","first-page":"603926","DOI":"10.3389\/fphar.2020.603926","volume":"11","author":"Cheng Peng","year":"2020","unstructured":"Peng, Cheng, Alastair G. Stewart, Owen L. Woodman, H. Rebecca, and Ritchie. 2020. Non-alcoholic steatohepatitis: A review of its mechanism, models and medical treatments. Frontiers in Pharmacology 11: 603926. https:\/\/doi.org\/10.3389\/fphar.2020.603926.","journal-title":"Frontiers in Pharmacology"},{"key":"2384_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Yana Geng","year":"2021","unstructured":"Geng, Yana, Klaas Nico Faber, E. Vincent, and Hans Blokzijl De Meijer, Han Moshage. 2021. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatology International 15:21\u201335. https:\/\/doi.org\/10.1007\/s12072-020-10121-2","journal-title":"Hepatology International"},{"key":"2384_CR8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","volume":"3","author":"Jaswinder K Sethi","year":"2021","unstructured":"Sethi, Jaswinder K., and G\u00f6khan S. Hotamisligil. 2021. Metabolic messengers: Tumour necrosis factor. Nature Metabolism 3:1302\u20131312. https:\/\/doi.org\/10.1038\/s42255-021-00470-z","journal-title":"Nature Metabolism"},{"key":"2384_CR9","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/jgh.15631","volume":"36","author":"Victoria Potoupni","year":"2021","unstructured":"Potoupni, Victoria, Maria Georgiadou, Eftychia Chatzigriva, Georgia Polychronidou, Erietta Markou, Christos Zapantis Gakis, Ioanna Filimidou, et al. 2021. Circulating tumor necrosis factor-\u03b1 levels in non\u2010alcoholic fatty liver disease: A systematic review and a meta\u2010analysis. Journal of Gastroenterology and Hepatology 36: 3002\u20133014. https:\/\/doi.org\/10.1111\/jgh.15631.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"2384_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","volume":"34","author":"J Crespo","year":"2001","unstructured":"Crespo, J. 2001. Gene expression of tumor necrosis factor [alpha ] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34:1158\u20131163. https:\/\/doi.org\/10.1053\/jhep.2001.29628","journal-title":"Hepatology"},{"key":"2384_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10238-015-0347-4","volume":"16","author":"Gabriela Paredes-Turrubiarte","year":"2016","unstructured":"Paredes-Turrubiarte, Gabriela, Antonio Gonz\u00e1lez-Ch\u00e1vez, Ruy P\u00e9rez-Tamayo, Beatriz Y.. Salazar-V\u00e1zquez, Vito S.. Hern\u00e1ndez, Nayeli Garibay-Nieto, Jos\u00e9 Manuel. Fragoso, and Galileo Escobedo. 2016. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Clinical and Experimental Medicine 16: 193\u2013202. https:\/\/doi.org\/10.1007\/s10238-015-0347-4.","journal-title":"Clinical and Experimental Medicine"},{"key":"2384_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41419-020-2411-6","volume":"11","author":"Franziska Wandrer","year":"2020","unstructured":"Wandrer, Franziska, Stephanie Liebig, Silke Marhenke, Arndt Vogel, Katharina John, Michael P. Manns, Andreas Teufel, et al. 2020. TNF-receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death & Disease 11: 212. https:\/\/doi.org\/10.1038\/s41419-020-2411-6.","journal-title":"Cell Death & Disease"},{"key":"2384_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gut.2005.071118","volume":"55","author":"K Tomita","year":"2006","unstructured":"Tomita, K. 2006. Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55:415\u2013424. https:\/\/doi.org\/10.1136\/gut.2005.071118","journal-title":"Gut"},{"key":"2384_CR14","doi-asserted-by":"publisher","first-page":"103549","DOI":"10.1016\/j.isci.2021.103549","volume":"25","author":"Maria Ramos","year":"2022","unstructured":"Ramos, Maria, Lucia Jimenez, Filippo Bandiera, Menolascina, and Fallowfield Jonathan Andrew. 2022. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications. IScience 25: 103549. https:\/\/doi.org\/10.1016\/j.isci.2021.103549.","journal-title":"IScience"},{"key":"2384_CR15","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.3390\/ijms232415791","volume":"23","author":"Christina-Maria Flessa","year":"2022","unstructured":"Flessa, Christina-Maria., Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, and Harpal S. Randeva. 2022. Genetic and diet-induced animal models for Non-Alcoholic fatty liver disease (NAFLD) research. International Journal of Molecular Sciences 23: 15791. https:\/\/doi.org\/10.3390\/ijms232415791.","journal-title":"International Journal of Molecular Sciences"},{"key":"2384_CR16","doi-asserted-by":"publisher","DOI":"10.33612\/diss.204505585","author":"Grietje Harmanna Prins","year":"2022","unstructured":"Prins, Grietje Harmanna. 2022. Metabolic-associated fatty liver disease: A major problem miniaturised. University of Groningen. https:\/\/doi.org\/10.33612\/diss.204505585","journal-title":"University of Groningen"},{"key":"2384_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu16050626","volume":"16","author":"Mei Li","year":"2024","unstructured":"Li, Mei, Frederik T.. Larsen, Marius C.. Van Den Heuvel, Konstanze Gier, Alan R.. Gorter, Dorenda Oosterhuis, Johan Bijzet, et al. 2024. Metabolic dysfunction-associated steatotic liver disease in a dish: Human precision-cut liver slices as a platform for drug screening and interventions. Nutrients 16: 626. https:\/\/doi.org\/10.3390\/nu16050626.","journal-title":"Nutrients"},{"key":"2384_CR18","unstructured":"Committee on Regulation of Health Research. Code of Conduct for Health Research. accessed on June 18, 2024. Availabe online: https:\/\/www.coreon.org\/wp-content\/uploads\/2023\/06\/Code-of-Conduct-for-Health-Research-2022.pdf"},{"key":"2384_CR19","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/nprot.2010.111","volume":"5","author":"AM De Graaf, Inge","year":"2010","unstructured":"De Graaf, Inge, A. M., Marina H Peter Olinga, T. De Jager, Marjolijn, Ruben De Merema, Esther G Kanter, Van De Kerkhof, M. M. Geny, and Groothuis. 2010. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nature Protocols 5:1540\u20131551. https:\/\/doi.org\/10.1038\/nprot.2010.111","journal-title":"Nature Protocols"},{"key":"2384_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G., and W. J. Dyer. 1959. A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION. Canadian Journal of Biochemistry and Physiology 37:911\u2013917. https:\/\/doi.org\/10.1139\/o59-099","journal-title":"Canadian Journal of Biochemistry and Physiology"},{"key":"2384_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OliverH Lowry","year":"1951","unstructured":"Lowry, OliverH., NiraJ Rosebrough, A. Lewis Farr, RoseJ, and Randall. 1951. PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT. Journal of Biological Chemistry 193:265\u2013275. https:\/\/doi.org\/10.1016\/S0021-9258(19)52451-6","journal-title":"Journal of Biological Chemistry"},{"key":"2384_CR22","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.4049\/jimmunol.178.12.7859","volume":"178","author":"Monther Al-Alwan","year":"2007","unstructured":"Al-Alwan, Monther, Qiujiang Du, Sen Hou, Baher Nashed, Yijun Fan, Xi. Yang, and JMarshall Aaron. 2007. Follicular dendritic cell secreted protein (FDC-SP) regulates germinal center and antibody responses. Journal of Immunology (Baltimore, Md.\u202f: 1950) 178: 7859\u20137867. https:\/\/doi.org\/10.4049\/jimmunol.178.12.7859.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2384_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","volume":"50","author":"Francisco Caballero","year":"2009","unstructured":"Caballero, Francisco, Anna Fern\u00e1ndez, M. Antonio, Jose C. De Lacy, Juan Fern\u00e1ndez-Checa, Caballer\u00eda, and Carmen Garc\u00eda-Ruiz. 2009. Enhanced free cholesterol, SREBP-2 and star expression in human NASH. Journal of Hepatology 50:789\u2013796. https:\/\/doi.org\/10.1016\/j.jhep.2008.12.016","journal-title":"Journal of Hepatology"},{"key":"2384_CR24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.13362","volume":"37","author":"JohnD. Clarke","year":"2017","unstructured":"Clarke, John D.., Petr Novak, April D.. Lake, Rhiannon N.. Hardwick, and Nathan J.. Cherrington. 2017. Impaired N-linked glycosylation of uptake and efflux transporters in human non\u2010alcoholic fatty liver disease. Liver International 37: 1074\u20131081. https:\/\/doi.org\/10.1111\/liv.13362.","journal-title":"Liver International"},{"key":"2384_CR25","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3390\/biomedicines10112686","volume":"10","author":"Lyubov S Klyushova","year":"2022","unstructured":"Klyushova, Lyubov S., Maria L. Perepechaeva, and Alevtina Y. Grishanova. 2022. The role of CYP3A in health and disease. Biomedicines 10:2686. https:\/\/doi.org\/10.3390\/biomedicines10112686","journal-title":"Biomedicines"},{"key":"2384_CR26","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1021\/acs.molpharmaceut.8b00159","volume":"15","author":"Rohitash Jamwal","year":"2018","unstructured":"Jamwal, Rohitash, Suzanne M.. De La Monte, Ken Ogasawara, Sravani Adusumalli, Benjamin B.. Barlock, and Fatemeh Akhlaghi. 2018. Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver. Molecular Pharmaceutics 15: 2621\u20132632. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00159.","journal-title":"Molecular Pharmaceutics"},{"key":"2384_CR27","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.1074\/jbc.RA119.008708","volume":"294","author":"Liang Guo","year":"2019","unstructured":"Guo, Liang, Ying-Ying Guo, Bai-Yu Li, Wan-Qiu Peng, Xin-Xia Chang, Xin Gao, and Tang Qi-Qun. 2019. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease. Journal of Biological Chemistry 294:11805\u201311816. https:\/\/doi.org\/10.1074\/jbc.RA119.008708","journal-title":"Journal of Biological Chemistry"},{"key":"2384_CR28","doi-asserted-by":"publisher","first-page":"149671","DOI":"10.1016\/j.bbrc.2024.149671","volume":"703","author":"Wonjun Cho","year":"2024","unstructured":"Cho, Wonjun, Heeseung Oh, A. M. Abd El-Aty, \u00d6mer \u00d6zten, Ji Hoon Jeong, and Jung Tae Woo. 2024. Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis. Biochemical and Biophysical Research Communications 703:149671. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149671","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2384_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.hbpd.2019.12.006","volume":"19","author":"Jian-Yong Zhuo","year":"2020","unstructured":"Zhuo, Jian-Yong, Di Lu, Zu-Yuan Lin, Bei-Ni Cen, Xu-Yong Wei, Hai-Yang Xie, Shu-Sen Zheng, and Xiao Xu. 2020. C C motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells. Hepatobiliary & Pancreatic Diseases International 19:440\u2013448. https:\/\/doi.org\/10.1016\/j.hbpd.2019.12.006","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"2384_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0167-4889(91)90207-E","volume":"1091","author":"SH Yap","year":"1991","unstructured":"Yap, S.H., H.J. Moshage, B.P.C. Hazenberg, H.M.J. Roelofs, J. Bijzet, P.C. Limburg, L.A. Aarden, and M.H. Van Rijswijk. 1991. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and\/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1091: 405\u2013408. https:\/\/doi.org\/10.1016\/0167-4889(91)90207-E.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"2384_CR31","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1038\/ctg.2016.72","volume":"8","author":"Laura E Dichtel","year":"2017","unstructured":"Dichtel, Laura E, E. Kathleen, Joseph Corey, Miriam A Misdraji, Melanie Bredella, Stephanie A Schorr, J. Osganian, Brian, Joshua C Young, Sung, and K Miller Karen. 2017. The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease. Clinical and Translational Gastroenterology 8:e217. https:\/\/doi.org\/10.1038\/ctg.2016.72","journal-title":"Clinical and Translational Gastroenterology"},{"key":"2384_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpeds.2014.01.052","volume":"165","author":"Stefano Cianfarani","year":"2014","unstructured":"Cianfarani, Stefano, Elena Inzaghi, Anna Alisi, Daniela Germani, and Antonella Puglianiello. 2014. Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children. The Journal of Pediatrics 165: 92\u201398. https:\/\/doi.org\/10.1016\/j.jpeds.2014.01.052.","journal-title":"The Journal of Pediatrics"},{"key":"2384_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/gut.2003.024505","volume":"54","author":"S Sanz","year":"2005","unstructured":"Sanz, S. 2005. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 54:134\u2013141. https:\/\/doi.org\/10.1136\/gut.2003.024505","journal-title":"Gut"},{"key":"2384_CR34","doi-asserted-by":"publisher","first-page":"46658","DOI":"10.1038\/srep46658","volume":"7","author":"Franck Chiappini","year":"2017","unstructured":"Chiappini, Franck, Audrey Coilly, Hanane Kadar, Philippe Gual, Albert Tran, Christophe Desterke, and Didier Samuel et al. 2017. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Scientific Reports 7:46658. https:\/\/doi.org\/10.1038\/srep46658","journal-title":"Scientific Reports"},{"key":"2384_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","volume":"91","author":"FrancisW. B. Sanders","year":"2016","unstructured":"Sanders, Francis W. B.., and Julian L.. Griffin. 2016. De novo lipogenesis in the liver in health and disease: More than just a shunting yard for glucose. Biological Reviews 91: 452\u2013468. https:\/\/doi.org\/10.1111\/brv.12178.","journal-title":"Biological Reviews"},{"key":"2384_CR36","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1042\/BCJ20210071","volume":"478","author":"Pascal Ferr\u00e9","year":"2021","unstructured":"Ferr\u00e9, Pascal. 2021. SREBP-1c and lipogenesis in the liver: An update. Biochemical Journal 478: 3723\u20133739. https:\/\/doi.org\/10.1042\/BCJ20210071.","journal-title":"Biochemical Journal"},{"key":"2384_CR37","first-page":"505","volume":"3","author":"Christoph Dorn","year":"2010","unstructured":"Dorn, Christoph, Marc-Oliver. Riener, Georgi Kirovski, Michael Saugspier, Kathrin Steib, Thomas S.. Weiss, Erwin G\u00e4bele, Glen Kristiansen, Arndt Hartmann, and Claus Hellerbrand. 2010. Expression of fatty acid synthase in nonalcoholic fatty liver disease. International Journal of Clinical and Experimental Pathology 3: 505\u2013514.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"2384_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04361-y","volume":"9","author":"Julien Bricambert","year":"2018","unstructured":"Bricambert, Julien, Marie-Clotilde. Alves-Guerra, Pauline Esteves, Carina Prip-Buus, Justine Bertrand-Michel, Herv\u00e9 Guillou, Christopher J.. Chang, et al. 2018. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nature Communications 9: 2092. https:\/\/doi.org\/10.1038\/s41467-018-04361-y.","journal-title":"Nature Communications"},{"key":"2384_CR39","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/hep.32324","volume":"76","author":"Mary P Moore","year":"2022","unstructured":"Moore, Mary P., P. Rory, Grace M. Cunningham, Sarah A. Meers, Andrew A. Johnson, Rama R. Wheeler, Nicole M. Ganga, and Spencer et al. 2022. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. Hepatology 76:1452\u20131465. https:\/\/doi.org\/10.1002\/hep.32324","journal-title":"Hepatology"},{"key":"2384_CR40","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JanardanK Reddy","year":"2006","unstructured":"Reddy, Janardan K., and M. Sambasiva Rao. 2006. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. American Journal of Physiology-Gastrointestinal and Liver Physiology 290: G852\u2013G858. https:\/\/doi.org\/10.1152\/ajpgi.00521.2005.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"2384_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"Rachel J Perry","year":"2014","unstructured":"Perry, Rachel J., T. Varman, F. Samuel, Kitt, Petersen, and Gerald I. Shulman. 2014. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510:84\u201391. https:\/\/doi.org\/10.1038\/nature13478","journal-title":"Nature"},{"key":"2384_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1194\/jlr.M300508-JLR200","volume":"45","author":"Tariq Tanoli","year":"2004","unstructured":"Tanoli, Tariq, Pin Yue, Dmitriy Yablonskiy, and Gustav Schonfeld. 2004. Fatty liver in Familial Hypobetalipoproteinemia. Journal of Lipid Research 45:941\u2013947. https:\/\/doi.org\/10.1194\/jlr.M300508-JLR200","journal-title":"Journal of Lipid Research"},{"key":"2384_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","volume":"20","author":"N Berriot-Varoqueaux","year":"2000","unstructured":"Berriot-Varoqueaux, N., L. P. Aggerbeck, M.-E. Samson-Bouma, and J. R. Wetterau. 2000. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annual Review of Nutrition 20:663\u2013697. https:\/\/doi.org\/10.1146\/annurev.nutr.20.1.663","journal-title":"Annual Review of Nutrition"},{"key":"2384_CR44","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/hep.23094","volume":"50","author":"Koji Fujita","year":"2009","unstructured":"Fujita, Koji, Yuichi Nozaki, Koichiro Wada, Masato Yoneda, Yoko Fujimoto, Mihoyo Fujitake, Hiroki Endo, et al. 2009. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 50: 772\u2013780. https:\/\/doi.org\/10.1002\/hep.23094.","journal-title":"Hepatology"},{"key":"2384_CR45","doi-asserted-by":"publisher","first-page":"154307","DOI":"10.1016\/j.metabol.2020.154307","volume":"110","author":"Efstathia Thymiakou","year":"2020","unstructured":"Thymiakou, Efstathia, Alaa Othman, Thorsten Hornemann, and Dimitris Kardassis. 2020. Defects in high density lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of hepatocyte nuclear factor 4A. Metabolism 110:154307. https:\/\/doi.org\/10.1016\/j.metabol.2020.154307","journal-title":"Metabolism"},{"key":"2384_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1194\/jlr.M025130","volume":"53","author":"Kezhi Dai","year":"2012","unstructured":"Dai, Kezhi, and M. Mahmood Hussain. 2012. NR2F1 disrupts synergistic activation of the MTTP gene transcription by HNF-4\u03b1 and HNF-1\u03b1. Journal of Lipid Research 53:901\u2013908. https:\/\/doi.org\/10.1194\/jlr.M025130","journal-title":"Journal of Lipid Research"},{"key":"2384_CR47","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/hep.31198","volume":"72","author":"Yu Lei","year":"2020","unstructured":"Lei, Yu, Joanne A. Hoogerland, Vincent W. Bloks, Trijnie Bos, Aycha Bleeker, Henk Wolters, and Justina C. Wolters et al. 2020. Hepatic carbohydrate response element binding protein activation limits nonalcoholic fatty liver disease development in a mouse model for glycogen storage disease type 1a. Hepatology 72:1638\u20131653. https:\/\/doi.org\/10.1002\/hep.31198","journal-title":"Hepatology"},{"key":"2384_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/nu10030321","volume":"10","author":"Hiroyuki Niwa","year":"2018","unstructured":"Niwa, Hiroyuki, Katsumi Iizuka, Takehiro Kato, Wudelehu Wu, Hiromi Tsuchida, Ken Takao, Yukio Horikawa, and Jun Takeda. 2018. ChREBP rather than SHP regulates hepatic VLDL secretion. Nutrients 10:321. https:\/\/doi.org\/10.3390\/nu10030321","journal-title":"Nutrients"},{"key":"2384_CR49","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1074\/jbc.M412107200","volume":"280","author":"Caroline Am\u00e9en","year":"2005","unstructured":"Am\u00e9en, Caroline, Ulrika Edvardsson, Anna Ljungberg, Lennart Asp, Peter \u00c5kerblad, Anna Tuneld, Sven-Olof Olofsson, Daniel Lind\u00e9n, and Jan Oscarsson. 2005. Activation of peroxisome Proliferator-activated receptor \u03b1 increases the expression and activity of microsomal triglyceride transfer protein in the liver. Journal of Biological Chemistry 280:1224\u20131229. https:\/\/doi.org\/10.1074\/jbc.M412107200","journal-title":"Journal of Biological Chemistry"},{"key":"2384_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"Christopher K Glass","year":"2012","unstructured":"Glass, Christopher K., and Jerrold M. Olefsky. 2012. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metabolism 15:635\u2013645. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.001","journal-title":"Cell Metabolism"},{"key":"2384_CR51","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"Ting Liu","year":"2017","unstructured":"Liu, Ting, Lingyun Zhang, Donghyun Joo, and Sun Shao-Cong. 2017. NF-\u03baB signaling in inflammation. Signal Transduction and Targeted Therapy 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2384_CR52","doi-asserted-by":"publisher","unstructured":"Vilar-Gomez, Eduardo, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, Marlen Castellanos, Rocio Aller-de La Fuente, Mayada Metwally, and Mohammed Eslam et al. 2018. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 155: 443\u2013457.e17. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.034","DOI":"10.1053\/j.gastro.2018.04.034"},{"key":"2384_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep4.1789","volume":"6","author":"Sonu Subudhi","year":"2022","unstructured":"Subudhi, Sonu, Hannah K.. Drescher, Laura E.. Dichtel, Lea M.. Bartsch, Raymond T.. Chung, Matthew M.. Hutter, Denise W.. Gee, et al. 2022. Distinct hepatic gene-expression patterns of NAFLD in patients with obesity. Hepatology Communications 6: 77\u201389. https:\/\/doi.org\/10.1002\/hep4.1789.","journal-title":"Hepatology Communications"},{"key":"2384_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/1354750X.2012.738249","volume":"18","author":"Hidenori Toyoda","year":"2013","unstructured":"Toyoda, Hidenori, Takashi Kumada, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Toshifumi Tada, and Yoshiki Murakami. 2013. Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases. Biomarkers 18:82\u201387. https:\/\/doi.org\/10.3109\/1354750X.2012.738249","journal-title":"Biomarkers"},{"key":"2384_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cccn.2004.06.028","volume":"349","author":"Dusanka Ljumovic","year":"2004","unstructured":"Ljumovic, Dusanka, Ioannis Diamantis, Athanasios K. Alegakis, and Elias A. Kouroumalis. 2004. Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases. Clinica Chimica Acta 349:203\u2013211. https:\/\/doi.org\/10.1016\/j.cccn.2004.06.028","journal-title":"Clinica Chimica Acta"},{"key":"2384_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcp.20948","volume":"211","author":"Chunhong Yan","year":"2007","unstructured":"Yan, Chunhong, and Douglas D. Boyd. 2007. Regulation of matrix metalloproteinase gene expression. Journal of Cellular Physiology 211:19\u201326. https:\/\/doi.org\/10.1002\/jcp.20948","journal-title":"Journal of Cellular Physiology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02384-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:19:22Z","timestamp":1788481162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02384-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02384-4","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}